(Q48399609)

11 February 2018

title

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. (English)

1 reference

11 February 2018

0 references

0 references

Stoiser B

1

1 reference

11 February 2018

Mörtl D

2

1 reference

11 February 2018

Hülsmann M

3

1 reference

11 February 2018

Berger R

4

1 reference

11 February 2018

Struck J

5

1 reference

11 February 2018

Morgenthaler NG

6

1 reference

11 February 2018

Bergmann A

7

1 reference

11 February 2018

Pacher R

8

1 reference

11 February 2018

publication date

1 November 2006

1 reference

11 February 2018

European Journal of Clinical Investigation

published in

1 reference

11 February 2018

volume

36

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

771-778

1 reference

11 February 2018

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Vasopressin as vasopressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Possible vascular role of increased plasma arginine vasopressin in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

Chronic vasopressin V(1A) but not V(2) receptor antagonism prevents heart failure in chronically infarcted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01724.X

10.1111/J.1365-2362.2006.01724.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018